Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Delving into Protagonist Therapeutics, Inc.'s Phase 2b ANTHEM-UC data of icotrokinra and the treatment space of for ulcerative colitis

Ticker(s): PTGX

Who's the expert?

Institution: Northwest Hospital

Gastroenterologist and VP of Medical Affairs at Northwest Hospital in Baltimore, Maryland
Currently manages 50+ patients with MASH and over 100 GERD patients
Clinical interest in GERD, polypectomy, and liver biopsy

Interview Goal

This discussion will explore the current treatment space for ulcerative colitis, with a focus on the Phase 2b ANTHEM-UC data.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here To Join
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

10Hours Left to Join Project

Call Date: Feb 05, 2026
Call Time: 08:30 AM EST

Wall Street Time

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here To Join
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.